セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/18 | 1,461 | 1,502 | 1,445 | 1,451 | +39 | +2.8% | 185,700 |
| 2024/03/15 | 1,469 | 1,469 | 1,398 | 1,412 | -54 | -3.7% | 172,500 |
| 2024/03/14 | 1,416 | 1,507 | 1,415 | 1,466 | +55 | +3.9% | 350,900 |
| 2024/03/13 | 1,469 | 1,496 | 1,355 | 1,411 | -88 | -5.9% | 538,400 |
| 2024/03/12 | 1,387 | 1,650 | 1,381 | 1,499 | +94 | +6.7% | 1,317,200 |
| 2024/03/11 | 1,499 | 1,525 | 1,380 | 1,405 | -35 | -2.4% | 288,000 |
| 2024/03/08 | 1,411 | 1,467 | 1,403 | 1,440 | +20 | +1.4% | 237,700 |
| 2024/03/07 | 1,508 | 1,520 | 1,410 | 1,420 | -80 | -5.3% | 340,400 |
| 2024/03/06 | 1,437 | 1,539 | 1,430 | 1,500 | +121 | +8.8% | 497,200 |
| 2024/03/05 | 1,375 | 1,403 | 1,370 | 1,379 | -26 | -1.9% | 145,700 |
| 2024/03/04 | 1,421 | 1,427 | 1,358 | 1,405 | -9 | -0.6% | 205,700 |
| 2024/03/01 | 1,364 | 1,430 | 1,364 | 1,414 | +43 | +3.1% | 291,300 |
| 2024/02/29 | 1,359 | 1,378 | 1,321 | 1,371 | +8 | +0.6% | 145,800 |
| 2024/02/28 | 1,346 | 1,377 | 1,341 | 1,363 | +29 | +2.2% | 213,900 |
| 2024/02/27 | 1,345 | 1,361 | 1,316 | 1,334 | +19 | +1.4% | 163,500 |
| 2024/02/26 | 1,224 | 1,334 | 1,203 | 1,315 | +92 | +7.5% | 335,000 |
| 2024/02/22 | 1,242 | 1,250 | 1,202 | 1,223 | -18 | -1.5% | 226,700 |
| 2024/02/21 | 1,317 | 1,317 | 1,241 | 1,241 | -57 | -4.4% | 173,500 |
| 2024/02/20 | 1,328 | 1,330 | 1,289 | 1,298 | -14 | -1.1% | 122,000 |
| 2024/02/19 | 1,248 | 1,323 | 1,241 | 1,312 | +75 | +6.1% | 196,400 |
| 2024/02/16 | 1,197 | 1,252 | 1,196 | 1,237 | +42 | +3.5% | 175,900 |
| 2024/02/15 | 1,250 | 1,250 | 1,193 | 1,195 | -59 | -4.7% | 260,500 |
| 2024/02/14 | 1,265 | 1,268 | 1,235 | 1,254 | -29 | -2.3% | 134,500 |
| 2024/02/13 | 1,279 | 1,314 | 1,277 | 1,283 | +5 | +0.4% | 119,800 |
| 2024/02/09 | 1,299 | 1,303 | 1,270 | 1,278 | -22 | -1.7% | 89,200 |
| 2024/02/08 | 1,296 | 1,313 | 1,272 | 1,300 | -8 | -0.6% | 115,000 |
| 2024/02/07 | 1,315 | 1,344 | 1,281 | 1,308 | -35 | -2.6% | 153,700 |
| 2024/02/06 | 1,363 | 1,364 | 1,316 | 1,343 | -28 | -2% | 177,300 |
| 2024/02/05 | 1,314 | 1,388 | 1,288 | 1,371 | +56 | +4.3% | 247,500 |
| 2024/02/02 | 1,276 | 1,337 | 1,265 | 1,315 | +38 | +3% | 236,500 |
| 2024/02/01 | 1,235 | 1,280 | 1,235 | 1,277 | +28 | +2.2% | 161,400 |
| 2024/01/31 | 1,221 | 1,249 | 1,197 | 1,249 | +28 | +2.3% | 157,900 |
| 2024/01/30 | 1,230 | 1,246 | 1,198 | 1,221 | -9 | -0.7% | 236,700 |
| 2024/01/29 | 1,235 | 1,249 | 1,224 | 1,230 | -8 | -0.6% | 103,200 |
| 2024/01/26 | 1,262 | 1,267 | 1,219 | 1,238 | -27 | -2.1% | 212,500 |
| 2024/01/25 | 1,215 | 1,279 | 1,187 | 1,265 | +50 | +4.1% | 292,500 |
| 2024/01/24 | 1,210 | 1,229 | 1,198 | 1,215 | +21 | +1.8% | 125,300 |
| 2024/01/23 | 1,233 | 1,241 | 1,193 | 1,194 | -15 | -1.2% | 140,400 |
| 2024/01/22 | 1,203 | 1,213 | 1,179 | 1,209 | +3 | +0.2% | 209,200 |
| 2024/01/19 | 1,217 | 1,236 | 1,201 | 1,206 | -16 | -1.3% | 122,600 |
| 2024/01/18 | 1,249 | 1,250 | 1,217 | 1,222 | -18 | -1.5% | 120,900 |
| 2024/01/17 | 1,269 | 1,271 | 1,240 | 1,240 | -52 | -4% | 214,600 |
| 2024/01/16 | 1,314 | 1,331 | 1,290 | 1,292 | -11 | -0.8% | 145,400 |
| 2024/01/15 | 1,282 | 1,308 | 1,260 | 1,303 | +32 | +2.5% | 132,800 |
| 2024/01/12 | 1,274 | 1,278 | 1,240 | 1,271 | -3 | -0.2% | 170,300 |
| 2024/01/11 | 1,280 | 1,282 | 1,254 | 1,274 | +5 | +0.4% | 147,700 |
| 2024/01/10 | 1,286 | 1,308 | 1,268 | 1,269 | -6 | -0.5% | 182,600 |
| 2024/01/09 | 1,278 | 1,300 | 1,258 | 1,275 | ±0 | ±0% | 146,100 |
| 2024/01/05 | 1,301 | 1,306 | 1,270 | 1,275 | -33 | -2.5% | 162,400 |
| 2024/01/04 | 1,252 | 1,308 | 1,230 | 1,308 | +29 | +2.3% | 171,900 |
351～
400
件表示中 / 1421件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 62,500円 | - | - | 0.80% | 48.56倍 | 2.10倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ステラファーマ | 41,600円 | +4.8% | - | 0.00% | - | 4.41倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| ラクオリア | 54,900円 | +25.1% | - | 0.00% | - | 2.14倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| Ｃｈｏｒｄｉａ | 18,300円 | - | - | 0.00% | - | 3.90倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| キッズバイオ | 25,400円 | - | - | 0.00% | - | 9.05倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
